Fresenius Kabi
88
6
6
60
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
18.2%
16 terminated/withdrawn out of 88 trials
78.9%
-7.6% vs industry average
41%
36 trials in Phase 3/4
13%
8 of 60 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (88)
Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy Participants
Role: lead
Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )
Role: collaborator
Plant-based Versus Animal-based Oral Nutritional Supplements
Role: collaborator
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Role: lead
Effect of Combined IV Bolus Amino Acid Supplementation and Mobilisation on Skeletal Muscle During the First 10 Days in the ICU: A RCT
Role: collaborator
The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck
Role: collaborator
Sucrosom5al Iron Supplementation in Blood Donors
Role: collaborator
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Role: lead
Investigating the Digestibility, Bioavailability and Utilisation of Varied Combined Protein Sources in Older Males Using a Dual Stable Isotope Tracer Technique
Role: collaborator
umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)
Role: collaborator
Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction
Role: collaborator
Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
Role: collaborator
Accelerated Recovery Following Opioid-free Anaesthesia in Supratentorial Craniotomy
Role: collaborator
Chronic Kidney Disease Observational Database - Taiwan
Role: lead
Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care
Role: lead
Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery
Role: lead
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Role: lead
The German Patient Blood Management Network
Role: collaborator
Use of 6% Hydroxyethylstarch (130/0.4) in Cardiac Surgical Patients
Role: collaborator
Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age
Role: lead